Suppr超能文献

高压氧联合口服类固醇治疗突发性聋:早期还是晚期?

Combination of Hyperbaric Oxygen Therapy and Oral Steroids for the Treatment of Sudden Sensorineural Hearing Loss: Early or Late?

机构信息

Department of Medicine, Surgery and Dentistry, University of Salerno, 84131 Salerno, Italy.

Department of Sense Organs, University La Sapienza, 00185 Rome, Italy.

出版信息

Medicina (Kaunas). 2022 Oct 10;58(10):1421. doi: 10.3390/medicina58101421.

Abstract

Background and Objectives: Several treatments are available for sudden sensorineural hearing loss (SSNHL), but no studies have compared the different treatments based on the delay from the onset of the disease. Our study aims to compare the effect of hyperbaric oxygen therapy (HBOT), oral steroids (OS) and combination of both therapies (HBOT + OS) for treating SSNHL. Materials and Methods: This randomized study analyzed 171 patients with SSNHL. Patients were evaluated by pure tone audiometry test (PTA) at baseline (T0) and 20 days after treatment (T1). Three groups were available HBOT-A-, OS-B- and HBOT + OS-C-. After baseline PTA, patients were randomly assigned to each group. Statistical analysis was performed by one-way ANOVA and Chi-square. Results: Patients in the HBOT + OS and HBOT groups improved their auditory function (p < 0.05). HBOT was the best choice for treatment when started by 7 days from SSNHL onset, while HBOT + OS in case of late treatment. Profound SNHL recovered equally by HBOT and HBOT + OS (p < 0.05). Upsloping SNHL obtained better auditory results by HBOT compared to HBOT + OS (p < 0.05). Downsloping and flat SSNHL had the most improvement with HBOT + OS compared to HBOT only (p < 0.05). Conclusions: Combination of HBOT and OS is a valid treatment for SSNHL both in case of early and late treatment. Combination of HBOT and OS was the choice with the best results in case of treatment started >14 days from symptom onset.

摘要

背景与目的

突发性聋(SSNHL)有多种治疗方法,但没有研究根据发病时间的不同来比较不同的治疗方法。我们的研究旨在比较高压氧治疗(HBOT)、口服类固醇(OS)和联合两种疗法(HBOT+OS)治疗 SSNHL 的效果。

材料与方法

这项随机研究分析了 171 例 SSNHL 患者。患者在基线(T0)和治疗后 20 天(T1)时进行纯音听阈测试(PTA)评估。有三组可供选择:HBOT-A、OS-B 和 HBOT+OS-C。在基线 PTA 后,患者被随机分配到每个组。采用单因素方差分析和卡方检验进行统计学分析。

结果

HBOT+OS 和 HBOT 组的患者听觉功能得到改善(p<0.05)。HBOT 是发病后 7 天内开始治疗的最佳选择,而 HBOT+OS 则是晚期治疗的最佳选择。HBOT 和 HBOT+OS 均可使重度 SNHL 得到相同程度的恢复(p<0.05)。HBOT 比 HBOT+OS 更能改善上斜型 SNHL 的听力结果(p<0.05)。HBOT+OS 比仅 HBOT 更能改善下斜型和水平型 SSNHL 的听力(p<0.05)。

结论

HBOT 和 OS 的联合治疗是 SSNHL 的有效治疗方法,无论是早期治疗还是晚期治疗。在发病后 14 天开始治疗的情况下,HBOT 和 OS 的联合治疗是选择最佳的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90f5/9611781/63188b61b07c/medicina-58-01421-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验